Pieris Pharma (PIRS) Earnings
|
Expand Research on PIRS
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -230.2% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -0.5% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/1/24 | Q224 | N/A | -$0.03 | N/A | N/A | $2.24M | N/A | N/A | N/A | ||
| 5/8/24 | Q124 | N/A | -$0.06 | N/A | N/A | $2.24M | N/A | N/A | N/A | ||
| 3/27/24 | Q423 | N/A | -$0.12 | N/A | N/A | $2.24M | N/A | N/A | N/A | ||
| 11/27/23 | Q323 | N/A | -$0.11 | N/A | N/A | $7.74M | N/A | N/A | N/A | ||
| 11/20/23 | Q323 | N/A | -$0.11 | N/A | N/A | $7.74M | N/A | N/A | N/A | ||
| 11/13/23 | Q323 | N/A | -$0.11 | N/A | N/A | $7.74M | N/A | N/A | N/A | ||
| 11/8/23 | Q323 | N/A | -$0.11 | N/A | N/A | $7.74M | N/A | N/A | N/A | ||
| 8/28/23 | Q223 | N/A | -$0.16 | N/A | N/A | $4.02M | N/A | N/A | N/A |
